Transparency Market Research presents this most up-to-date research on “Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019“
Overview of the Medical Imaging Reagents Market
The global medical imaging reagents market has received an impetus from a rise in the incidence of cardiovascular diseases and cancer. Medical imaging reagents are unique chemical compounds in that they help diagnosticians and medical care providers determine the malignancy or benignancy of a tumor. Reagents have been found to be a fairly reliable method of establishing the presence of metastatic cancer in a patient. The presence of reagents during medical imaging helps better identify suspicious growths and tumors in the body.
This report segments the imaging reagents market based on three aspects: Class, applications, technology type, and geographical region. Based on products, the market has been segmented into the following types of reagents: Contrast, optical and nuclear reagents. On the basis of technology, the segments analyzed in the report include: Nanoparticles, radiopharmaceuticals, fluorescent proteins, fluorescent dyes, quantum dots, and probes.
Similarly, on the basis of applications, the medical imaging reagents market has been split into three distinct segments: Diagnostics, research and development, and drug discovery and development.
In recent years, the use of technologies such as biochips, polymerase chain reaction (PCR), DNA sequencing, and hybrid imaging modalities has caught on. All of these technologies rely on medical imaging reagents that are highly sensitive, so as to produce enhanced images. As a result, the growth of the medical imaging reagents market will be directly proportional to the deployment of innovative technologies in healthcare and diagnostic technologies market.
The most influential drivers in the medical imaging reagents market are: A palpable increase in the demand for functional imaging and diagnostic technologies, the sheer compatibility of reagents in various applications and an increased emphasis on patient safety. On the other hand, a short supply of materials and high development cost of reagents could adversely impact the market in the coming years. To counter the impact of these market restraints, companies could focus on opportunities such as development of nuclear products for personalized therapies.
The medical imaging reagents market is categorized on the basis of class, technology and applications. The three main classes of imaging reagents are contrast reagents, optical reagents and nuclear reagents. The contrast reagents market of the medical imaging reagents accounted for the largest market in 2011 (44%). However, the nuclear reagents market is expected to experience the fastest growth rate during the forecast period owing to the high adoption rate for localized tracers and nuclear medicine. Moreover, the technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. Among these, nanoparticles technology is expected to grow at a high growth rate of over 8% from 2013 to 2019 due to the widespread applicability of these technologies along with high research and development initiatives being taken up for the development of their application areas. Furthermore, in terms of applications, this market is categorized into diagnostics, drug discovery and development as well as research and development; among which, drug discovery and development is expected to witness the highest growth during the forecast period. This growth can be attributed to the growing adoption rate of medical imaging reagents in the pre-clinical studies and medical interventions. However, diagnostic applications accounted for the largest market in terms of revenue due to the escalating patient base of chronic diseases (e.g. cancer, cardiovascular and neurological diseases).
View Full Report at : http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html
The research report further covers a vendor analysis of the global medical imaging reagents market including company overview, inception details, financial overview, business strategies, mergers and acquisitions, and recent developments. The prominent players operating in the market include Thermo Fisher Scientific, Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging SpA, Bayer Healthcare AG, Lantheus Medical Imaging, Inc., Siemens Healthcare, and GE Healthcare.
Key segments of the Medical Imaging Reagents market:
Global Medical Imaging Reagents Market Segmentation, by Class
Global Medical Imaging Reagents Market Segmentation, by Technology
Global Medical Imaging Reagents Market Segmentation, by Application
Drug discovery and development
Research and development
Global Medical Imaging Reagents Market Segmentation, by Geography
Rest of the World (RoW)
Download Sample Copy of Report at :
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453